Gene expression profiling of breast cancer: A new tumor marker

[11] Hayes Daniel F., 2004, P51

[12] Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 305 - 319

[13] Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1456 - 1466

[14] Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 976 - 983

[15] Khan J, 1998, CANCER RES, V58, P5009

[16] Paik S, 2003, BREAST CANCER RES TR, V82, pS10

[17] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) : 2817 - 2826

[18] Paik S, 2004, BREAST CANCER RES TR, V88, pS15

[19] Distinctive gene expression patterns in human mammary epithelial cells and breast cancers [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) : 9212 - 9217

[20] Molecular portraits of human breast tumours [J]. NATURE, 2000, 406 (6797) : 747 - 752

[11] Hayes Daniel F., 2004, P51

[12] Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 305 - 319

[13] Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20): : 1456 - 1466

[14] Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) : 976 - 983

[15] Khan J, 1998, CANCER RES, V58, P5009

[16] Paik S, 2003, BREAST CANCER RES TR, V82, pS10

[17] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) : 2817 - 2826

[18] Paik S, 2004, BREAST CANCER RES TR, V88, pS15

[19] Distinctive gene expression patterns in human mammary epithelial cells and breast cancers [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) : 9212 - 9217

[20] Molecular portraits of human breast tumours [J]. NATURE, 2000, 406 (6797) : 747 - 752